心脏膜疾病:从机制到管理
Fabien Praz1, Friedhelm Beyersdorf2, Kristina Haugaa3
1University Hospital Bern Inselspital, University of Bern, Bern, Switzerland.
在全球范围内,心脏膜疾病正在增加. 新的成像和外科进展使得多学科团队能够进行个性化治疗,改善复杂患者的护理.
科学领域:
- 心脏病学
- 心脏外科
- 医学成像
背景情况:
- 全球心脏膜疾病的患病率正在上升.
- 目前的医疗疗法还不够.
- 外科手术在历史上是有限的, 服务不足的老人和虚弱的患者.
研究的目的:
- 提供当前和未来心脏膜疾病管理的概述.
- 提供个性化的治疗方法.
- 突出多学科心脏团队的作用.
主要方法:
- 对成像和手术技术的进步进行回顾.
- 对心脏膜疾病管理的证据基础分析.
- 强调了解疾病的病理生理学.
- 应用多学科治疗策略.
主要成果:
- 20年来心脏膜疾病管理的显著变化.
- 更好地了解疾病的机制和原因.
- 开发一个个性化治疗平台.
- 建立专业的心脏门中心和网络.
结论:
- 多学科心脏团队对于个性化心脏病治疗至关重要.
- 在诊断和治疗方面取得的进展为人们带来了新的希望.
- 未来的管理依赖于将病理生理知识与基于团队的策略整合起来.
更多相关视频
12:12Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
Published on: February 14, 2017
07:41A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
Published on: March 1, 2022
相关概念视频
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Pathophysiology of Heart Failure
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiovascular Drugs: Classification based on Therapeutic Indications
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
